Insulet
PODD
NASDAQ
IPO2007
about PODD
Insulet is a company that develops and sells the Omnipod Insulin Therapy System, a tubeless insulin delivery system designed for people with diabetes to manage their condition without the need for traditional infusion pumps or multiple daily injections.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $350.68 | $351.11 | $330.00 | $24.61B | 411.00K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.32 | 76.00 | 37.14 | 18.66% | 3.47% | 0% |